134 related articles for article (PubMed ID: 10830861)
1. Synthetic analogs for oxovanadium(IV/V)-glutathione interaction: an NMR, EPR, synthetic and structural study of oxovanadium(IV/V) compounds with sulfhydryl-containing pseudopeptides and dipeptides.
Tasiopoulos AJ; Troganis AN; Deligiannakis Y; Evangelou A; Kabanos TA; Woollins JD; Slawin A
J Inorg Biochem; 2000 Apr; 79(1-4):159-66. PubMed ID: 10830861
[TBL] [Abstract][Full Text] [Related]
2. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
[TBL] [Abstract][Full Text] [Related]
3. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
4. The effect of charged axial ligands on the EPR parameters in oxovanadium(IV) compounds: an unusual reduction of the Az (51V) values.
Tolis EJ; Teberekidis VI; Raptopoulou CP; Terzis A; Sigalas MP; Deligiannakis Y; Kabanos TA
Chemistry; 2001 Jun; 7(12):2698-710. PubMed ID: 11465461
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of the multiple vanadium-oxygen bonds in the central VO(eta2-O2)+ group. Synthesis, structure, supramolecular interactions and DFT studies for complexes with 2,2'-bipyridine, 1,10-phenanthroline, pyrazinato(1-) and pyrazinamide ligands.
Pacigová S; Gyepes R; Tatiersky J; Sivák M
Dalton Trans; 2008 Jan; (1):121-30. PubMed ID: 18399238
[TBL] [Abstract][Full Text] [Related]
6. DNA cleavage by new oxovanadium(IV) complexes of N-salicylidene alpha-amino acids and phenanthroline bases in the photodynamic therapy window.
Sasmal PK; Patra AK; Nethaji M; Chakravarty AR
Inorg Chem; 2007 Dec; 46(26):11112-21. PubMed ID: 18020327
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
8. Photocytotoxicity and DNA cleavage activity of L-arg and L-lys Schiff base oxovanadium(IV) complexes having phenanthroline bases.
Sasmal PK; Majumdar R; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Aug; 39(30):7104-13. PubMed ID: 20563340
[TBL] [Abstract][Full Text] [Related]
9. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
10. An eight-coordinate vanadium thiolate complex with charge delocalization between V(V)-thiolate and V(IV)-thiyl radical forms.
Chang YH; Su CL; Wu RR; Liao JH; Liu YH; Hsu HF
J Am Chem Soc; 2011 Apr; 133(15):5708-11. PubMed ID: 21438583
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, DNA binding and DNA cleavage activity of oxovanadium(IV) N-salicylidene-S-methyldithiocarbazate complexes of phenanthroline bases.
Sasmal PK; Patra AK; Chakravarty AR
J Inorg Biochem; 2008 Jul; 102(7):1463-72. PubMed ID: 18279964
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
13. EPR investigation of the oxovanadium(IV) complexes formed by the tripeptide glutathione and some related ligands in aqueous solution.
Dessì A; Micera G; Sanna D
J Inorg Biochem; 1993 Dec; 52(4):275-86. PubMed ID: 8120532
[TBL] [Abstract][Full Text] [Related]
14. The mode of reduction of vanadate(+V) to oxovanadium(+IV) by glutathione and cysteine.
Legrum W
Toxicology; 1986 Dec; 42(2-3):281-9. PubMed ID: 3026064
[TBL] [Abstract][Full Text] [Related]
15. Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy.
Mustafi D; Makinen MW
Inorg Chem; 2005 Aug; 44(16):5580-90. PubMed ID: 16060607
[TBL] [Abstract][Full Text] [Related]
16. Complexes of cis-dioxomolybdenum(VI) and oxovanadium(IV) with a tridentate ONS donor ligand: synthesis, spectroscopic properties, X-ray crystal structure and catalytic activity.
Fayed AM; Elsayed SA; El-Hendawy AM; Mostafa MR
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():293-302. PubMed ID: 24747851
[TBL] [Abstract][Full Text] [Related]
17. Vanadium-based, extended catalytic lifetime catechol dioxygenases: evidence for a common catalyst.
Yin CX; Finke RG
J Am Chem Soc; 2005 Jun; 127(25):9003-13. PubMed ID: 15969577
[TBL] [Abstract][Full Text] [Related]
18. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
19. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
[TBL] [Abstract][Full Text] [Related]
20. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.
Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J
Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
